Visitors Now:
Total Visits:
Total Stories:
Profile image
By Global Market Insights Inc.
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

China Biosimilar Drug Industry, Analysis, Research, Trends, Growth to 2021

Friday, October 7, 2016 2:56
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “China Biosimilar Drug Market by Manufacturers, Type and Application, Forecast to 2021” new report to its research database. The report spread across 101 pages with table and figures in it.

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:

This report focuses on the Biosimilar Drug in China market. This report categorizes the market based on manufacturers, type and application.

Market Segment by Manufacturers, this report covers

CP Guojian



Henlius Biotech


Eli Lilly


Changchun High Tech


Browse full table of contents and data tables @

Market Segment by Type, covers

  • Injection
  • Tablets
  • Others

Market Segment by Applications, can be divided into

  • Ankylosing Spondylitis
  • Tumor
  • Rheumatoid Arthrtis
  • Cardiovascular

Request a sample copy @

Chapter 1, to describe Biosimilar Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilar Drug, with sales, revenue, and price of Biosimilar Drug, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4 and 5, to show the market of Biosimilar Drug by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 6, Biosimilar Drug market forecast, by type and application, with sales and revenue, from 2016 to 2021;

Chapter 7, to analyze the Biosimilar Drug market development potential except China, covering China, Southeast Asia, India, Latin America etc.

Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.

Inquiry Before Buying @

To receive personalized assistance, write to us @ with the report title in the subject line along with your questions or call us at +1 866-764-2150

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.